Endothelial progenitor cells (EPCs) have been isolated and shown to be effective in animal
models of ischemia, and many groups involved in clinical trials have demonstrated that EPC …

Given the rising prevalence of cardiovascular disease worldwide and the limited therapeutic
options for severe heart failure, novel technologies that harness the regenerative capacity of …

Background Pilot trials suggest that the intracoronary administration of autologous
progenitor cells may improve left ventricular function after acute myocardial infarction …

Although clinical trials of autologous whole bone marrow for cardiac repair demonstrate
promising results, many practical and mechanistic issues regarding this therapy remain …

Adult neovascularization relies on the recruitment of circulating cells, but their angiogenic
roles and recruitment mechanisms are unclear. We show that the endothelial growth factor …

Background The benefit of reperfusion therapies for ST-elevation acute myocardial infarction
(STEMI) is limited by post-infarction left-ventricular (LV) dysfunction. Our aim was to …

Background Previous studies have shown improvement in left ventricular function after
intracoronary injection of autologous cells derived from bone marrow (BMC) in the acute …

Long-term noninvasive cell tracing by fluorescent probes is of great importance to life
science and biomedical engineering. For example, understanding genesis, development …

Background—Intracoronary transfer of autologous bone marrow cells (BMCs) may enhance
recovery of left ventricular (LV) function in patients after acute myocardial infarction (AMI) …

Coronary artery disease (CAD) is one of the most common causes of death worldwide. In the
last decade, significant advancements in CAD treatment have been made. The existing …